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T 2 ' - deoxythymidine
pT 2' - deoxythymidine - 5 - phosphate




12-^C) 2 ' - deoxythymidine
m
P T 12-^cl 2 ' - deoxythymidine - 5 ' - phosphateAP Tp I2-**CJ 2' - deoxythymidine - 3 ' - 5' -
bisphosphate
PN.dPfPN/JPOj p - nitrophenylphosphate
PN0 p - nitrophenol
3'-dGMP 2 ' - deoxyguanosine - 3 ' - phosphate
2'-AMP adenosine - 2 ' - phosphate
PEP Phosphoenolpyruvate
Introjuction
In 1970, Elinor F. Brunngraber and Erwin Chargaff 
isolated an ensyme from E.. coll that catalysed the transfer 
of phosphate from various organic donors to the free 2 * and 
2 ' hydroxyls of nucleoside and nucleotide acceptors (1 ). 
Because nucleotides were found to accept transferred 
phosphate more readily than nucleosides, the ensyme was 
called nucleotide phosphotransferase (2). Among the many 
compounds surveyed by Brunngraber and Chargaff pN?p and 3'- 
dGMP were reported as among the most efficient donors (3). 
The ensyme is also able to transfer the phosphate to the 3'- 
hydroxyl of oligonucleotides< Thymidine oligomers up to six 
residues long have been found that accept phosphate from 
donors at their 3'-terminal hydroxyl in a reaction cataylsed 
by nucleotide phosphotransferase ( 4) .
The biological function of this ensyme is not known. 
Brunngraber and Chargaff have shown that nucleotide 
phosphotransferase will phosphorylate NAD4* to form NADP.
(5) This has lead to speculation that the ensyme could be 
an alternative to NAD kinase and ATP in synthesising NADP. 
Another possible function is seen in the ability of 
nucleotide phosphotransfrase to phosphorylate the 3'- 
hydroxyl of thymidine oligomers. With many cellular 
processes requiring a free 3 '-hydroxyl, nucleotide 
phosphotransfrase could be acting as regulatory agent. Some
of processes that would be inhibited by a lack of 3 '- 
hydroxyl include the changing of t-RNA, the replication of 
DNA and the transcription of RNA.
The ability of nucleotide phosphotransfrase to 
phosphorylate the 3'-hydroxyl could make it a useful tool in 
experiments that require the in-vitro phosphorylaton of 
oligonucleotides at the 3'-hydroxyl. Possible uses of this 
would include labeling for sequencing or binding studies and 
the protection of 3'-hydroxyl by phosphosphorylation during 
T4 RNA ligase catalysed synthetic reactions (6 ). The 
ability to use nucleotide phosphotransfrase to accomplish 
3'-phosphorylaton would be a significant improvement because 
current methods of 3'-phosphorylation are complicated. They 
involve the addition of a single 5'-labelled ribonucleotide 
to the 3'-hydroxyl of the oligmer using various enzymatic 
methods or by chemical synthesis and then removing the 
ribonucleotide by periodate oxidation followed by beta- 
elimination to leave the desired 3'-labelled product (7).
If 3'dGMP should be an excellent donor for this enzyme, it 
could provide an easily obtainable source of labelled 3'- 
phosphates due to the availability of labelled 13'- 
32PldGMP. Labelled 3'-dGMP can be synthesised from [at-32P] 
dGTP, which is obtainable commercially. First |fc-32P]GTP 
would be polymerised into a poly(dG) by deoxynucleotide 
terminal transferase which will add K - 32PldGTP onto a
oligodeoxyguanosine primer. The poly (dG) chain would then 
be cleaved by DNase II and spleen phosphodiesterase to yield 
the desired product, (3'~^Pl dGMP (8).
The focus of this work is to identify a linear range 
for the assay of the enzyme and using that information to 
survey a wide range of potential donors to find one with a 
low Km . If a donor is found with a sufficiently low Km » 
nucleotide phosphotransfrase could become a useful tool in 
laboratory biochemistry.
Materials and Methods
Materials. E. coli W397e cells were supplied by 
Charles Pratt of the University of Illinois Microbiology 
Department. Nucleotide phosphotransferase was isolated from 
£* c°li by Steven Marquez using a purification scheme 
developed in this lab (9). pNOp was supplied by Aldrich 
Chemicals. The 3'-dGMP was from Pharmacia. All other 
donors surveyed were from Sigma Corporation. The |2'-14C)
2'-deoxythymidine-5'-phosphate was from ICN. Thin layer 
chromatograms, type PEI-300, were obtained from Brinkmann 
Instruments. The TLC sheets were scanned in the radio thin- 
layer chromatograph, manufactured by Radiomatic Instruments 
and Chemical Co., model RS.
The assay procedure used was based on the following 
reaction.
pN^p + p*T --- > pN0 + p Tp
For the experiments to determine the linear range, the assay
*contained 100 mM pNOp as the donor. 20 mM p T as the 
acceptor and 0.1 M NaOAc (pH 5.0) as the buffer. Different 
enzyme concentrations were tested in a total reaction volume 
of 20 ul. Enzyme was diluted in 0.1M NaOAc (pH 5.0) and 10 
ul was added to start the reaction.
Each reaction was incubated at 37* C for the desired 
time. The reaction was stopped by adding 5 ul of IN KOH. 
Aliquots (5 ul) of the reaction mixture were spotted onto a 
20x20 cm PEI-300 TLC sheet. Each TLC contained a standard 
lane of 140 nmoles each of T. pT and pTp. The TLC plate was 
developed by ascending chromatography at 37* C with 0.8M 
LiCl. The plates were dried with cool air. The nucleotides 
on the plates were visualized under ultraviolet light and 
their position marked (Figure 1). The standard lane 
contained three spots corresponding to pTp. pT and T. An 
assay lane usually had spots with Rf values corresponding to 
the pTp and pT standards. The radioactivity in each lane 
was then quantified by the scanner.
For surveying donors, the assays contained a
concentrated donor solution* 13*33 mM p*T and 0*1 M NaOAc 
(pH 5*0). The donors were tested at 1500 uM, 500 uH, and 
100 uM* The final volume in each assay tube was 30 ul*
Some assays had different concentrations of donor, acceptors 
and other reagents and these conditions are noted where 
appropriate* Bach reaction was incubated at 37*c for the 
desired time* At the indicated time, an aliquot of 7.5 ul 
was removed from the tube and added to 2*5 ul of IN KOH to 
stop the reaction* An aliquot (5 ul) of this mixture was 
spotted on the PEI-300 TLC plates* Each plate contained the 
same standards mentioned previously but the concentration of 
pTp, pT and T were reduced to 70 nmoles. The lowered 
concentration improved the resolutions of the standards when 
they are developed* Also, the TLC plates were developed at 
4*C to improve resolution of the standards*
The extent of reaction in each assay, referred to as t 
pTp, for both studies, was determined from the output of 
radioactivity as determined by the scanner. Each plate was 
scanned and by comparing the patterns of ultraviolet 
ates&rbences'of the TLC plate and the radioactive prof ile, 
the identity of each radioactive peak could be determined* 
The percent pTp was determined by dividing the radioactivity 
In the pTp peak by that in the pTp and pT peaks* The 
background in other areas of the chromatogram was




It was necessary to determine the range of the enzyme
concentration over which the assay was linear in order to
perform the donor survey. The linear range for nucleotide
phosphotransferase was studied previously by Satya Khuon in
our laboratory. She reported the assay to be linear between
30 ug/ml and 60 my/ml (10). The enzyme was tested at
concentrations ranging from 2.5 ug/ml and 60 ug/ml. Time
points were taken at 0, 3, 7, 13, 20, 30 and 60 minutes.
Each reaction was analyzed as described in Methods. The
results of these experiments are shown in Table 1 and the
graph of those results is shown in figure 2. The fact that
the I pTp produced in Figure 2 does not go through zero can
probably be explained by two different factors. First,
there is some product formed even when the reactions are run
with a boiled enzyme. This shows that the collisions of two 
* *p T molecules can form p Tp. The second factor is the 
approximately 20-30 seconds that elapses between the time I 
add the enzyme to start the reaction and the aliquot is 
added to the KOH to stop the reaction. These two factors 
probably account for the non-zero value. Based on those 
results nhown, I determined that the linear range for
9nucleotide phosphotransferase was from 10 ug/ml to 40 
ug/ml. A graph of velocity versus enzyme concentration also 
indicates this result (Figure 3). Based on these results# I 
selected 30 ug/mi as the enzyme concentration for use in the 
survey of donors.
The results of the donor survey will be presented in
two parts. The first will be the data obtained from
surveying the various donors using a nucleotide
phosphotransferase concentration of 30 ug/ml. The second
will be the data obtained when# in an effort to produce more 
*
p Tp# the concentration of nucleotide phosphotransferase was 
first raised to 60 ug/ml and then lowered to 45 ug/ml.
As described in the materials section# the procedures 
for these experiments involved assaying various donors at 
three different concentrationst 1500 uM# 500 uM and 100 uM 
and taking measurements at 0 # 15 and 60 minutes.
Brunngraber and Chargaff had previously performed a donor 
survey and their results were used to narrow the list of 
donors to be assayed (11). Because the reaction now had a 
donor concentration of 1500 uM or less# I performed several 
assays with 3'-dGMP and pN^p to confirm that the reaction 
would work at the lower donor concentration and that there 
would be enough pTp present to successfully# formed from a 
donor# to detect on the scanner. In the course of doing 
these trials# I determined that developing the TLC plates at
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4°C improved the separation of the nucleotides. Also# 
reducing the concentration of the standards to 35 mM alvo 
improved their resolution. The results of each assay on a 
donor were compared to a 31-dGMP standard donor. 3'-dGMP 
was chosen as the standard because Brunnqraber and Chargaff 
had previously reported it as the best donor. A scan of the 
results of an assay with 3*-dGMP and another donor are shown 
in Figures 4 and 5. As can be seen# the amount of p*Tp is 
greater in the assay using 31-dGMP as the donor# the amount 
of product formed is not very great. The results for this 
donor survey are presented in Table 3. The results with 
each donor are presented normalised with respect to 3'-dGMP 
at each surveyed concentration and at each time point. The 
results showed that the best donors# listed from best to 
worst aret 3*-dGMP# 2*-AMP# Acetyl Coenzyme A(Li* salt)# 
PEP# Phosphatidyl choline# Phosphocreatine# pN/Jp, thymidine- 
31# 5’-diphosphate and Fructose-1# 6-diphosphate. Inactive 
donors were 0-phoaphosorine# Ribose-l-phosphate and 
Tyrosine-phosphate. Since only a small amount of product 
was produced it was difficult to make meaningful comparisons 
between donors. As a result# it was suggested to increase 
the extent of the reaction so that the % pTp produced would 
be approximately 201 after 15 minutes of reaction. As 
initially performed (Table 3)# the maximum y<eld of pTp was 
12 percent after 60 minutes. Also# the amount of
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radioactivity in the reaction was increased to increase the 
specific activity of the product. An extra 4 uCi of p*T was 
added to the stock solution of 40 mM pT in 0.100 M NaOAc (pH 
5.0). The addition of an extra 4 uCi of p*T increased the 
counts found in the stock solution from around 8,000 to 
almost 20,500 counts.
After increasing the specific activity of the 
substrate, an assay was performed using 1500 uM B'-dGMP as 
the donor and nucleotide phosphotransfrase concentrations of 
30, 40, 50 and 60 ug/ml. This assay was performed twice and 
the results of both assays showed no increase in product as 
the concentration of enzyme was increased. Despite the 
increase in enzyme concentration, the amount of product 
stayed the same, reaching a maximum of lit with 60 ug/ml 
enzyme. The anticipated result was that increasing the 
enzyme concentration would increase the amount of product. 
This was the result of my earlier studies with nucleotide 
phosphotransferase (Figure 2). To confirm the latter 
result, I performed the assay again with freshly-made 3 •- 
dGMP and ptytfp as donors at the different enzyme 
concentrations. This would confirm that the donors were not 
responsible for the failure to form increased amounts of 
product. The fresh solutions did not change the amount of 
product formed. I also confirmed the concentration of pT in 
the stock solution by spectrophotometry. Chromatography of
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the stock solution by development on a PEI-300 TLC plate 
with 0.8 M LiCl revealed that only p T was present in the 
stock.
The assays again using 60 ug/ml of enzyme were again
repeated. At this point, I noticed that the scans were
showing three distinct peaks rather than the two that had
been observed previously (Figure 6). Knowing that the
labeled carbon originated in the thymidine moiety of the 
*p T, I suspected that the new peak was thymidine but looking 
at the TLC plate under ultraviolet light showed only one 
spot with Rf of pT. But as Figure 6 showe, there are three 
distinct radioactive peaks present in this reaction. This 
result was observed several times with both 3'-dGMP and pNOp 
as donors. A possible explanation for the lack of a third 
peak was that the concentration of the nucleotide was too 
low for it to be visualized. This was suspected because in 
earlier studies no product would be seen under UV but a scan 
would reveal product with an Rf corresponding to the known 
pTp standard. The appearance of thymidine suggested there 
was a phosphatase present in the reaction mixture and this 
phosphatase was competing with nucleotide 
phosphotransferase. In my next experiment, I switched the 
source of ensyme. I used another concentrated solution of 
nucleotide phosphotransferase but this change also did not 
affect the effects. The appearance of the third was still
observed and at the same level as before. Knowing that
there was a distinct third peak and suspecting that the
third peak was thymidine, I decided to investigate the
possible phosphatase activity that was producing the
thymidine, A phosphatase is an enzyme that removes
phosphate from phosphate containing compounds. In our case,
* * *it would cause the formation of Tp from p Tp and T from 
*p T. A phosphatase can work either on the 3* or 5* 
phosphate or on both phosphates, I next investigated 
various enzyme concentrations to see what effect enzyme 
concentration has on the phosphatase activity. This 
experiment showed that decreasing the enzyme concentration 
decreased the phosphatase activity. Also, I added 5 and 10 
mM KH2P04 to some of the assays because many phosphatases 
are inhibited by their product. This experiment showed that 
decreasing the enzyme concentration decreased the 
phosphatase activity. The addition of 5 and 10 mM KH2P0 4 
did not inhibit the phosphatase as expected but actually 
seemed to stimulate the formation of thymidine. The 
addition of 10 mM KH2P04 increased the amount of thymidine 
formed in IS minutes of reaction from 5,0% to 13*31, The 
contradiction was that the data from the study of the linear 
range showed no phosphatase activity whatsoever, even at 
high enzyme concentrations incubated at 37*C for up to 60 
minutes. Phosphatase activity was now present at lower
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enzyme concentrations in only 15 minutes of reaction.
To continue my attempts to resolve the contradictory 
findings, I remade all the reagents. This included new 
NaOAc buffer, 3'-dGMP and pN/fp and p T  solutions. I 
continued to 60 ug/ml as the concentration for nucleotide 
phosphotransferase. The result of this experiment again 
showed phosphatase activity. Its activity was such that 
after 60 minutes of incubation at 37*c, the third peak 
accounted for 30% of the radioactivity in the assay while 
the product accounted for less than 2% of the 
radioactivity. This TLC was developed on film for 72 hours 
at -70#C to confirm that the third peak was a separate peak 
not smeared pT peak. The film confirmed that there was a 
distinct third peak migrating with an Rf of thymidine.
I then repeated the assays as done in the experiments 
determining the linear range, where no phosphatase activity 
was seen. For this experiment, pN^p at 200 mM was the 
donor, the nucleotide phosphotransferase concentration was 
60 ug/ml and the concentration of the acceptor, pT, was 
16.67 mM. The results of this experiment are displayed in 
Figures 7 and 8. Figures 7 and 8 show a large product peak 
after 15 minutes of reaction but a much smaller product peak 
after 60 minutes of reaction. Neither time point shows any 
thymidine. The phosphatase activity was still present.
This is shown by the decrease in product with increasing
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reaction time* The phosphatase will cleave p*Tp leaving
*Tp* Unfortunately, *Tp and p*T comigrate on the TLC sheet 
and we are unable to tell what forms are present in pT 
peak* The extent of the phosphatase can be seen by looking 
at the data from this experiment* After 15 minutes of 
reaction, 741 of the radioactivity was present as p*Tp, the 
product of nucleotide phosphotransferase. After 60 minutes
of reaction, 441 of the radioactivity was present in the
# * *form of p Tp with the remainder as p T or T p. The
phosphatase was responsible for this decrease in product by 
removing the S'-phosphate from p Tp. I thon tried various 
donor and enzyme concentrations. I tried pN0p at 15 mM, 
enzyme at 60 ug/ml; 3'-dGMP at 5.0 mM, «nzyme at 45 ug/ml. 
The results of this experiment showed that by lowering the 
enzyme concentration to 45 ug/ml, the activity of the 
phosphatase was greatly reduced and the amount of product, 
pTp, started to approach the values I had obtained from 
earlier experiments. I examined the preparation of 
nucleotide phosphotransferase in a 15« SDS gel to compare it 
to the enxyme used in the past. A picture of the SDS gel is 
presented in Figure 9. Lane 1 is the nucleotide 
phosphotransferase that was used in the earlier study. Lane 
2 is the pre-affinity column fraction from the enzyme 
purification used in the later studies. Lane 3 is the 
concentrated solution of enzyme from the same
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purification* This latter solution is the source for all 
other enzyme solutions on the gel* Lane 4 is a one to three 
dilution of lane 3* Lane 5 is a one to two dilution of Lane 
4. Lane 5 is the enzyme at the dilution used in the latest 
experiments* Lane 6 contains markers* Lanes 4 and 5 have a 
band in them that is not seen in Lane 3* This is 
unexplainable since the protein in lane 3 is the source for 
lanes 4 and 5* Also, the proteins in lanes 3, 4, 5 all 
exhibited phosphatese activity when I tested them* Lane 1 
is the enzyme solution from the linear range study that 
never exhibited any phosphatase activity. Unfortunately, l 
only had enough enzyme to run the gel and not enough to use 
in assays* When comparing lane 1 to lanes 2, 3, 4 there is 
a band in lanes 2, 3, 4 that is not present in lane 1. This 
may be the band that is causing the phosphatase activity but 
this remains to be established*
The effects on 10 mM KH2PO4 on the phosphatase activity 
were also examined in this experiment* The addition of 10 
mM KH2PO4 to a solution containing 20 mM p*T and 45 ug/ml 
nucleotide phosphotransferase doubled the activity of the 
phosphatase an judged by the increase in the amount of 
thymidine formed. For the solution with no KHjPO^ added, 
the amount of thymidine produced after 15 minutes reaction 
wee 11.9% while a solution with 10 mM KH2PO4 added had 23.5% 
thymidine produced after 15 minutes of reaction* The effect
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of KH2PQ4 °n reacti°n will be investigated further*
The next experiment investigated «u- effect KH2PO4 had 
on the phosphotransferase reaction* Assays of 31-dGMP 
solutions in the presence of different concentrations of 
KH2PO4 and comparing these to solutions in which no donor 
was present* The control solutions had 13*33 mMpT, 45 ug/ml 
nucleotide phosphotransferase and various concentrations of 
KH2PO4 * It was expected that some product would be seen in 
the reactions with no donor because pT can itself function 
as a donor when no other donor is present. When pT acts a 
donor, thymidine is produced and this must be considered 
when determining the amount of thymidine produced by the 
phosphatase. The results of this experiment are presented 
in Table 4. A graph of % Thymidine versus concentration of 
KH2P04 is seen in Figure 10. These results show that in the 
absence of donor, the phosphatase activity is stimulated.
The result that was expected when KH2PO4 concentrations were 
increased was that the phosphatase activity would be 
inhibited. The result 1 found, based on the incomplete 
survey of KH2PC>4 concentrations, was that the phosphatase 
activity was not inhibited by increased KH2PO4 
concentrations but rather the activity was stimulated.
Having found that phosphatase activity could be kept at 
a minimum when the enzyme concentration was 45 ug/ml, I 
decided to conduct a final survey of donors with that
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concentration for my enzyme. To ensure that the donor was 
not depleted by the reaction, I brought the donor and 
acceptor concentrations closer together. For this survey, 
donor concentration was 5.0 mM and the acceptor, pT, 
concentration was 6.67 mM, it was hoped this would maximize 
nucleotide phosphotransferase activity and minimize 
phosphata se activity. The results of this survey are shown 
in Tables 5 and 6 . The data shows several interesting 
results. If you compare the donors after 15 minutes of 
reaction, pNOp is the best donor, producing 182.2% more pTp 
than does 31-dGMP but if the donors are compared after 30 
minutes of reaction, pN/Jp produces only 86.7% of the 
product, pTp, when compared to 3*-dGMP. The donors, 
compared after 30 minutes of reaction, are listed as 
normalized to 3*-dGMP from best to worst? 3*-dGMP, pNOp, 
Acetyl Coenzyme A (1^ + salt), thymidine-3*,5'-diphosphate, 
CoA(Na+ salt), Acetyl CoA(Na* salt), Phosphocreatine, 
Fructose-1, 6-diphosphate, PEP, 2*-AMP and Phosphatidyl 
choline. These results are surprising because previous 
experiments had established 2*-AMP as an excellent donor and 
my earlier experiments had shown some of the worst donors 
here had looked were promising. The donor seems to 
influence the level of phosphatase activity. Donors that 
led to a high phosphatase activity include PEP, 
Phosphocreatine and Phosphatidyl choline.
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In attempting to find reaction conditions that would 
allow testing of the lipid derivative doliehol phosphate as 
a donor, solutions containing various amounts of ethanol 
were tested* The results of these experiments showed that 
nucleotide phosphotransfrase were inhibited by ethanol, but 
that phosphatase was active in solutions containing up to 
40% (v/w) ethanol. At 40% ethanol, the phosphatase activity 
was greatly reduced compared to lower percentages of ethanol 
but activity was still present. In 10% ethanol solutions, 
the extent of thymidine after 15 minutes of reaction was 
6.4%. In addition, the phosphatase was also active in 40% 
DMSO, whereas nucleotide phosphotransferase was not.
Because of my inability to find a solution where doliehol 
phosphate was soluble and nucleotide phosphotransferase 
active, I have been unable to determine if doliehol 
phosphate would function as a donor*
Discussion
The results of initial studies show the reaction is 
linear with respect to enzyme concentration and that the 
assay is reproducable. The reaction was linear with 10 
ug/ml to 40 ug/ml of nucleotide phosphotransferase. Using 
enzyme concentrations within this range, the survey of 
donors was performed* Based on the results of the final 
donor survey (Tables 5 and 6 ), the relationship between
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donor and acceptor concentration is extremely important* 
Because the acceptor, pT, can also act as a donor when 
another donor is not present, the surveyed donor 
concentration must be high relative to the pT concentration 
to ensure that nucleotide phosphotransferase is primarily 
using the test donor as its phosphate source* One must also 
be aware that the enzyme can use pT if the test donor is 
consumed•
If the test donor is consumed or the acceptor 
concentration is too high relative to the donor 
concentration, the reaction will then bet
* * * *p T ♦ p T --- > p Tp + T
(donor) (acceptor)
A
This reaction will produce T as shown and this result could 
be interpreted as being due to a phosphatase when there is 
not* This possibility had to be considered when I was 
analyzing my data but was insufficient to explain all of the 
thymidine produced* In the final donor survey, where the 
donor concentration was 5.0 mM and the acceptor 
concentration was 6*66 mM, the amount of thymidine produced 
is too great to be explained by pT acting as a donor. The 
reactions in the final donor survey had almost egual donor 
and acceptor concentrations, yet there was thymidine peaks
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with 45% of the radioactivity while the pTp peak contains 
only 2*5% of the radioactivity. This data supports the 
possibility that something else besides nucleotide 
phosphotransferase is present. If this is a phosphatase as 
suspected, the expected result for the final donor survey, 
based on equal acceptor concentrations for almost all 
donors, would be the same phosphatase activity in all 
assays. Since the phosphatase acts primarily on the 
acceptor, pT, it would be reasonable to assume that amount 
of phosphatase activity would not depend on the nature of 
the donor. The results of the final donor survey show an 
unexpected result, the activity of the phosphatase appears 
to depend on the nature of the donor. Donors such as 3'- 
dGMP, pt^ 0p, Acetyl CuA (Li+ and Na* salt), CoA(Na* salt) and 
thymidine-31, 5'-diphosphate all showed a high level of 
activity with nucleotide phosphotransferase while the donors 
2'-AMP, phoshatidyl choline, PEP and Phosphocreatine all 
showed a high level of activity with the phosphatase. This 
was surprising because these donors had been previously 
identified as good donors for nucleotide
phosphotransferase. Since all donors were freshly made up 
in the NaOAc buffer, results should not reflect any 
degradation by the acidic buffer. The only donor that 
showed no observable phosphatase activity, either formation 
of thymidine or degradation of product was 3*-dGMP* Ail
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other donors showed some degree of phosphatase activity*
The data for pNOp are especially striking* In the first 15 
minutes of reaction there is a high level of nucleotide 
phosphotransferase acti/ity, resulting in the formation of 
45*0% product with only 0.51 T. In the next 15 minutes, the 
product decreases suggesting a high level of phosphatase 
activity resulting in only 23.5% product after 30 minutes. 
The amount of T stays constant over the reaction, suggesting 
that only the p is removed from the product pTp. This 
degradation of product after the first minutes of reaction 
was also seen in assays using Acetyl CoA(Li+ and Ns* salt), 
CoAfNa* salt) and thymidine-31 ,5'-diphosphate. This result 
of the nature of the donor affecting the phosphatase 
activity was not expected just as the result of addition of 
KH2PO4 to the reaction.
1 expected that the addition of KH2PO4 might inhibit 
the reaction since many phosphatases are inhibited by their 
product P p  The phosphatase activity was in fact not 
inhibited by the addition of KH2PO4 but instead as the 
concentration of KH2PO4 was increased, the phosphatase 
activity increased. Due to a lack of time, I was unable to 
perform an assay with sodium arsenate added. Arsenate 
interferes with the phosphatase by occupying the phosphate 
site and forming an unstable comound which is immediately 
hydrolyzed. Determining whether inactivating the
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phosphatabe also inactivates the phosphotransferase activity 
might show if the two enzyme activities are part of one 
enzyme or separate enzymes. If inactivating the phosphatase 
also inactivates the phosphotransferase, it might suggest 
the activities are part of one enzyme molecule. If 
inactivating the phosphatase does not inhibit the 
phosphotransferase, it might suggest the two enzymes are 
separate. Also surprising, was the fact that the 
phosphatase was active in organic solvents that inhibited 
nucleotide phosphotransferase activity.
Brunngraber and Chargaff noted the phosphatase activity 
of nucleotide phosphotransferase (12). Their comment on the 
phosphatase activity was that in the presence of a suitable 
acceptor the phosphatase activity of the transferase is 
greatly, if indeed not completely, inhibited. They do not 
report any phosphatase activity when a suitable donor and 
acceptor are present, like I have observed.
To extend this investigation, I would propose to 
investigate the effects of KH2PO4 on the phosphatase 
activity, perform assays with sodium arsenate and to 
investigate the donor-acceptor relationship on phosphatase 
activity. I would also confirm the phosphatase results by 
redoing these experiments on the next enzyme purification 
and see if the results are reproducable. If the results are 
consistent from purification to purification, the
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phosphatase activity might help explain the biological 
function of this enzyme by providing clues to possible
functions a combined phosphotransferase-phosphatase enzyme 
might have.
Table 1
RESULTS OF LINEAR RANGE EXPERIMENTS
Reaction time (minutes)
0 3 7 1 3 2 0
3 0
4 0 1 6 . 4 4 9 . 6 7 0 . 3 7 6 . 2 7 9 . 2 8 0 . 5
m 1 4 . 6 3 5 . 0 4 3 . 1 5 6 . 6 7 4 . 6 7 6 . 0
& 1 2 . 6 2 1 . 1 3 2 . 4 4 8 . 2 5 5 . 7 1 7 . 3
1 1 2 1 . 6 a s 2 6 .Q 3 4 . 3 3 6 . 0 4 5 . 3
5 1 * 3 1 0 . 3 2 1 . 0 2 2 . 5 2 3 . 6 2 7 . 6
i
TARLEl % pTp PRODUCED IN UNEAR RANGE EXPERIMENTS
Reaction* were performed as described in Methods section.
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Table 2
REACTION VELOCITY OF LINEAR RANGE EXPERIMENTS
enzyme
roicantriti on
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Rxn Time 0 15 30
3'*dG)IP
3.75mM 1.2 1.8 1.5
control 















3.7SmM 1.0 0.6 2.0
w/20mM KH2P04
control 













3.7SaM 4.3 4.7 3.6
*/40mM KB2P04
control 
(no donor) 5.0 19.2 20.7
w/SOmM KB2P04
3'-dGMP
3.75mM 7.0 1.3 2.7
w/50mM XS2P04
control 
(no donor) 5.3 20.9 33.3
w/250»X ABP04
Y'dGMP
3.7fanX 5.7 2.7 4.5
v/250«M XBSP04
control
(no donor) 5.4 11.9 19.9
f t m * *  RMN&Tt OP VAAVRlfi NMiP04 ON AMOUNT OP THYftUOINK PftODUCID
TibltS
j fa t* 4 w * coRc. ra  taw jlpTpjTpr IT
1 (aM) (auftfttfslj i
! T-*B» 10 0 1.7 94.9 0.8i **i j IS 94,7 71.4 OS
! i *• i 3Q ; 17.1 171.7! 0.S
U i 2 L _ ! 10 5 4.9 ‘ 93.21 0.9*# j IS 44.0 192.5 1.0
»# •0 30 a s  7*3 2.3
r -u tf 15 0 i 2.1 '» . ! 0.4M M 15 I to i«7.i 7.0 1H H 30 j 1.4 !t|.7 17.3!
* —llftuiil Mm 10 s ! 2.2 '9t.4( 0.4
•0 •« IS f 3.0 44.1 10.3
1------- ------------U 0 i l l  W.J 4.1
1 " ! " I IS 1 3.4 93.4i 30.4
M 1 ....’* 1 30 ! IS 4l.Sl4S.li
mmmm* . H 1 0 j 1.0 ,91414.: '
H
1711117.11
** 1 30 i 4J 0*0127.2!
AiCoA^Soltr ... " ! 0 ! 13 ! 74.411141
•* .... " | 11 11.4 170.4119.91
*
" ! 30 I 4.4 179.4 i 9.7 :
A9C94ji.4*tt #* S 11 !9 t t i  14 1
IS ^14.7 179.21 3.7 i
•* * 30 114177,1! 14
CoAJIft+Sftit M 0 t o 93.3111 !
*9 « r  IS 1*0 1414! 14
H *$ 30 10.4 4141 3.4
t s i *
a 0 *1 S U *4  ;
(9 * U 10.0 7*1 u  1
*9 49 f 30 t u 1*1 4.0!
S T
•9 0 3.3 04.0 1.1
19 *4 IS a 00.S *1
•9 * Si * 1 0*1 * 1
• 0 1.1 03.1 4.0 1
n • IS 4.5 90.0 3.1 j
49
- 30 3.2 0*S i d
TaU« 5 RESULTS OF DONOR SURVEY
Nucleotide pfaoapfeotransfoaie coaceatratkw wm 45 ug/aL All reactions wan incubated at 37C
TABLE*
DONOR SURVEY RESULTS
5* 555?  | -------------
N « * 8* H
A c C o A .
L i* S * l t
C o A .N *  +  
S a l t
f — \
8 8 8.0 8 8 8.0 8.0 8.0
m  ttam rn o 18 8© © 18 8© O 18 80 © 18 8© © 18 80 O 18 80
*  * • » i . y 84.7 87.1 ©8 8 8 8 88.8 8.8 118 8.4 8.1 14.7 18.0 8 8 18.0 10.4 8.1 198 11.8
- - «a» 870.8 1888 88.7 188.8 4 7 1 — 188.8 80.8 40.1 188.4 48.0 88.3 108.3 7 0 8 41.8
* * * " ^ : r,: nM * m 2* - A8 P C i
( h a
a f i t r e i l
f m M J
8.© 8 8 8 8 8 8 -----------1— 8.8
o 18 8© © 18 8© © 18 80 © 18 80 © 18 80 o 18 3©
n 8 8 *.0 8.1 8 8 8 8 1 8 4 8 4 8 4 8 8 8 1 8 8.1 8.8 8.4 1 8 4.8 3.8
© * ©  8© o O ©©8
am M  p r a t e M i
m i 1 * 8 7 8 1888
~ ’© 8 111.7 108 •08 — 11.7 0 8 188.8 188 0 8 ©4.1 108 118
Reactions were performed at 37* C for
Figure I. A TYPICAL SEPARATION OF PRODUCTS lit fM ASSAY REACTION
The patterns shorn were obtained from a developed 
PEI—300 chromatogram while visualizing spots under 
ultraviolet illumination. The plate mm* developed at 4*0#C with 0.8 n L i d .
Figure 2 LINEAR RANGE RESULTS 
Reaction* were ran with the condition! ai listed 





. = 40 ug/ml 
» = 30 ug/ml 
n = 80 ug/ml 
* s  10 ug/ml 
. 3 05 ug/ml
Figure 3 UNEAR RANGE FOR REACTION VELOCITY 
Reactions were run with the conditions 
at listed in the methods section 
for the linear range assay.
«Mjme conceaAmttoa (ug/ul)




??*?.0r * DONOR SURVEY ASSAY USING THYMIDINE­
S’ #?‘-DIPNOStHATE AS THE DONOR.Reaction condit
1063
S C A N  O f  A  OONOK  
Maction condition* 
donor and Uill R|
U tX N O  3 , - d f l « f  M
# 506 M J » 
u  ttat aeeoOMHF*
.figura i*
SCAM OP A DONOR ASSAY USING ' pNjfp.
Reaction conditions wars 200 mM pNOp as ths donor 
And 16.67 atM pT as ths acceptor. Nucleotids 
phosphotransferase concentration was 60 u«/»l. 
ths reaction ets incubated at 37 »c for 15 minutes 
before being stopped with IN RON.
s&y  ^ - *
*fr s«rr  * * ,'w ~ * s  ,<*■* •» _'
Figure 8. SCAN OF A DONOR ASSAY USING pN0p
Reaction conditions were 200 mM pNOp at the donor 
and 1S.S7 b M pT as the acceptor. Nucleotide 
phosphotranaterase concentration was SO -g/nU . 
The reaction was incubated at 3?*C for SO minutes 
before being stopped with IN RON.
6
Figure 10-X THYMBWl  PBOBVCKB 
CONCHfflUTiWt OF KH2P04
to m  m  m  m m
im m
. coofcroHno donor)usaj* 
, 3'dGMP m i j i
X-axis scale 
adjustment
..'.Hi**.. _ . . .  _________________________  . . .  ........................... ___________________________ . . . . . . .................. •
References
1. Brunngraber, E. F. 
Acad. Sci. USA 67,
& Chargaff E. 
107-122.
2. Brunngraber, E. F. 
Acad. Sci. USA 67,
& Chargaff, E 
107-112.
3. Brunngraber, E. F. 
12, 3005-3011.
& Chargaff, E
4. Brunngraber, E. F. 
12, 3005-3011.
i Chargaff, E




. (1970) Proc. Natl.
. (1973) Biochemistry 
• (1973) Biochemistry 
. (1973) Biochemistry
6 . Detloff, P. J. (1985) Thesis for Bachelor of Science in 
Liberal Arts and Science, 1-19,
7. Fisher, J. R. (1986) Thesis for Bachelor of science in 
Liberal Arts and Science, 1-15.
8. Marques, Steve (1988) Lab Procedure.
9. Khuon, Saxya (1987) Lab Notebook.
10. Khuon, Satya (1987) Lab Notebook.
11. Brunngraber, E. F. I Chargaff, E. (1973) Biochemistry
3005-3011.




My most sincere thanks and appreciation go to Dr. 
Richard I. Gumport, Mark Van Cleve, Eric Fisher, Chris 
Aiken, Wieeka Kaszubska, Shih-Tong Jang and Ke-Qin sun for 
their help and encouragement throughout the year, x would 
like to especially thank Steve Marquez for all his help and 
support.
